Showing results (961-970 of 1,211) with videos related to
Sort By:
Pageof 122
Nature Reviews. Nephrology|October 6, 2019
Sex and the kidneys: current understanding and research opportunitiesC Noel Bairey Merz, Laura M Dember, Julie R Ingelfinger, et al.Nature Communications|September 26, 2022
Single cell atlas of spinal cord injury in mice reveals a pro-regenerative signature in spinocerebellar neuronsKaya J E Matson, Daniel E Russ, Claudia Kathe, et al.British Journal of Haematology|March 22, 2016
Monoclonal gammopathy-associated pure red cell aplasiaNeha Korde, Yong Zhang, Kelsey Loeliger, et al.Cancer Letters|December 5, 2017
LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiationWinson S Ho, Saman Sizdahkhani, Shuyu Hao, et al.Blood|October 8, 2025
Phase 2 trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemiaBrett Schroeder, Constance M Yuan, Hao-Wei Wang, et al.Frontiers in Neuroscience|January 11, 2021
Comparative Analysis of Dorsal Root, Nodose and Sympathetic Ganglia for the Development of New AnalgesicsMatthew R Sapio, Fernando A Vazquez, Amelia J Loydpierson, et al.Leukemia|August 22, 2012
Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activationY Bai, G Bandara, E Ching Chan, et al.Molecular Biology of the Cell|September 3, 2010
Phosphorylation of p27Kip1 at Thr187 by cyclin-dependent kinase 5 modulates neural stem cell differentiationYa-Li Zheng, Bing-Sheng Li, Parvathi Rudrabhatla, et al.Haematologica|August 4, 2006
Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature reviewJane A Little, Vicki R McGowan, Gregory J Kato, et al.The Journal of Allergy and Clinical Immunology|February 18, 2014
The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disordersFanny Legrand, Nenad Tomasevic, Olga Simakova, et al.Pageof 122